Howard W. Robin
2010
In 2010, Howard W. Robin earned a total compensation of $4.5M as President and Chief Executive Officer at Nektar Therapeutics, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $700,000 |
|---|---|
| Option Awards | $3,018,950 |
| Salary | $758,581 |
| Other | $14,973 |
| Total | $4,492,504 |
Robin received $3M in option awards, accounting for 67% of the total pay in 2010.
Robin also received $700K in non-equity incentive plan, $758.6K in salary and $15K in other compensation.
Rankings
In 2010, Howard W. Robin's compensation ranked 1,198th out of 10,439 executives tracked by ExecPay. In other words, Robin earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,198 out of 10,439 | 89th |
Division Manufacturing | 441 out of 3,838 | 89th |
Major group Chemicals And Allied Products | 95 out of 921 | 90th |
Industry group Drugs | 55 out of 680 | 92nd |
Industry Pharmaceutical Preparations | 47 out of 481 | 90th |
Source: SEC filing on April 30, 2013.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2010.